12932928

Source:http://linkedlifedata.com/resource/pubmed/id/12932928

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0229671, umls-concept:C0279025, umls-concept:C0332293, umls-concept:C0441889, umls-concept:C0936223, umls-concept:C1514474, umls-concept:C1516213, umls-concept:C1550147, umls-concept:C1880904
pubmed:issue	3
pubmed:dateCreated	2003-8-22
pubmed:abstractText	The serum level of neuron specific enolase (NSE) is gaining acceptance as a marker of neuroendocrine tumors. To clarify the role of NSE in prostate cancer progression, we examined the relationship of NSE to clinicopathological parameters.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7512719
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Androgen Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/Phosphopyruvate Hydratase, http://linkedlifedata.com/resource/pubmed/chemical/Prostate-Specific Antigen, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological
pubmed:status	MEDLINE
pubmed:month	Sep
pubmed:issn	0302-2838
pubmed:author	pubmed-author:AkakuraKoichiroK, pubmed-author:IsshikiShinzouS, pubmed-author:ItoHaruoH, pubmed-author:KamiyaNaotoN, pubmed-author:KomiyaAkiraA, pubmed-author:SuzukiHiroyoshiH, pubmed-author:UedaTakeshiT
pubmed:issnType	Print
pubmed:volume	44
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	309-14; discussion 314
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:12932928-Adenocarcinoma, pubmed-meshheading:12932928-Aged, pubmed-meshheading:12932928-Androgen Antagonists, pubmed-meshheading:12932928-Bone Neoplasms, pubmed-meshheading:12932928-Follow-Up Studies, pubmed-meshheading:12932928-Humans, pubmed-meshheading:12932928-Male, pubmed-meshheading:12932928-Multivariate Analysis, pubmed-meshheading:12932928-Neoplasm Staging, pubmed-meshheading:12932928-Phosphopyruvate Hydratase, pubmed-meshheading:12932928-Predictive Value of Tests, pubmed-meshheading:12932928-Prognosis, pubmed-meshheading:12932928-Prostate-Specific Antigen, pubmed-meshheading:12932928-Prostatic Neoplasms, pubmed-meshheading:12932928-Retrospective Studies, pubmed-meshheading:12932928-Survival Analysis, pubmed-meshheading:12932928-Treatment Outcome, pubmed-meshheading:12932928-Tumor Markers, Biological
pubmed:year	2003
pubmed:articleTitle	Pretreatment serum level of neuron specific enolase (NSE) as a prognostic factor in metastatic prostate cancer patients treated with endocrine therapy.
pubmed:affiliation	Department of Urology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, Japan. akakurak@tkn-hosp.gr.jp
pubmed:publicationType	Journal Article, Comparative Study, Research Support, Non-U.S. Gov't